Back to state act
Description
On February 2, 2021, Edesa Biotech announced securing CAD 14 million (USD 11 million) from the Canadian government to complete the Phase 2 clinical studies of its investigational drug EB05 for the tre...
Sign in to see full description
Intervention Details
Intervention Type
State loan
MAST Chapter
L: Subsidies (excl. export subsidies)
Implementation date
02 Feb 2021
Revocation date
No revocation date
Implementation level
National
Affected flow
Inward
Announced as temporary
No
Eligible firms
firm-specific
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 6 products
Threads
See all
This intervention is not part of any Thread yet.